JP Patent

JP7833196B6 — ラコサミド医薬組成物、その製造方法及び応用

Assigned to 上海雲晟研新生物科技股▲ふん▼有限公司 · Expires 2026-04-20 · 0y expired

What this patent protects

Patent listed against Lyrica.

Drugs covered by this patent

Lyrica (Pregabalin) · Pfizer Inc.

Patent Metadata

Patent number: JP7833196B6
Jurisdiction: JP
Classification: —
Expires: 2026-04-20
Drug substance claim: No
Drug product claim: No
Assignee: 上海雲晟研新生物科技股▲ふん▼有限公司
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.